Clinical outcomes of stereotactic magnetic resonance image ‐guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis
ConclusionsFavorable LC and PFS outcomes were observed with minimal morbidity for tumors in the abdomen and pelvis treated with SMART. Future prospective clinical trials to validate these findings are warranted.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Stephanie M. Yoon,
Elaine Luterstein,
Fang ‐I Chu,
Minsong Cao,
James Lamb,
Nzhde Agazaryan,
Daniel Low,
Ann Raldow,
Michael L. Steinberg,
Percy Lee Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Cobalt | Gastroenterology | Pain | Respiratory Medicine | Toxicology